Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahiko Shimura

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
Japanese Journal of Ophthalmology|June 5, 2003
Choroiditis in systemic lupus erythematosus: systemic steroid therapy and focal laser treatmentMasahiko Shimura, Yuko Tatehana, Kanako Yasuda, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 18, 2006
Neuroprotective effect of latanoprost on rat retinal ganglion cellsHideyo Kudo, Toru Nakazawa, Masahiko Shimura, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|November 11, 2016
Cytokines and Recurrence of Macular Edema after Intravitreal Ranibizumab in Patients with Branch Retinal Vein OcclusionHidetaka Noma, Tatsuya Mimura, Kanako Yasuda, et al.
American Journal of Ophthalmology|March 11, 2008
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edemaMasahiko Shimura, Toru Nakazawa, Kanako Yasuda, et al.
Medicina (Kaunas, Lithuania)|January 26, 2024
Role of Novel Inflammatory Factors in Central Retinal Vein Occlusion with Macular EdemaKanako Yasuda, Hidetaka Noma, Tatsuya Mimura, et al.
Retina (Philadelphia, Pa.)|August 13, 2011
Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edemaMasahiko Shimura, Kanako Yasuda, Toru Nakazawa, et al.
Translational Vision Science & Technology|December 26, 2024
Changes in Aqueous Angiopoietin-1/2 Concentrations During the Induction Phase of Intravitreal Faricimab Injections for Diabetic Macular EdemaMasahiko Shimura, Shotaro Sasaki, Ryota Nonaka, et al.
Journal of Neuroscience Research|August 28, 2007
ERK1 plays a critical protective role against N-methyl-D-aspartate-induced retinal injuryToru Nakazawa, Masahiko Shimura, Morin Ryu, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 4, 2018
Phase II/III Clinical Trial of Sub-Tenon Injection of Triamcinolone Acetonide (WP-0508ST) for Diabetic Macular EdemaYuichiro Ogura, Masahiko Shimura, Tomohiro Iida, et al.
Antioxidants (Basel, Switzerland)|May 27, 2026
Involvement of Oxidative Stress-Related Inflammatory Mediators in the Pathogenesis and Treatment Response of Macular Edema Secondary to Branch Retinal Vein OcclusionTakuto Yamamoto, Hidetaka Noma, Tatsuya Mimura, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
Japanese Journal of Ophthalmology|June 5, 2003
Choroiditis in systemic lupus erythematosus: systemic steroid therapy and focal laser treatmentMasahiko Shimura, Yuko Tatehana, Kanako Yasuda, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 18, 2006
Neuroprotective effect of latanoprost on rat retinal ganglion cellsHideyo Kudo, Toru Nakazawa, Masahiko Shimura, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|November 11, 2016
Cytokines and Recurrence of Macular Edema after Intravitreal Ranibizumab in Patients with Branch Retinal Vein OcclusionHidetaka Noma, Tatsuya Mimura, Kanako Yasuda, et al.
American Journal of Ophthalmology|March 11, 2008
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edemaMasahiko Shimura, Toru Nakazawa, Kanako Yasuda, et al.
Medicina (Kaunas, Lithuania)|January 26, 2024
Role of Novel Inflammatory Factors in Central Retinal Vein Occlusion with Macular EdemaKanako Yasuda, Hidetaka Noma, Tatsuya Mimura, et al.
Retina (Philadelphia, Pa.)|August 13, 2011
Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edemaMasahiko Shimura, Kanako Yasuda, Toru Nakazawa, et al.
Translational Vision Science & Technology|December 26, 2024
Changes in Aqueous Angiopoietin-1/2 Concentrations During the Induction Phase of Intravitreal Faricimab Injections for Diabetic Macular EdemaMasahiko Shimura, Shotaro Sasaki, Ryota Nonaka, et al.
Journal of Neuroscience Research|August 28, 2007
ERK1 plays a critical protective role against N-methyl-D-aspartate-induced retinal injuryToru Nakazawa, Masahiko Shimura, Morin Ryu, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 4, 2018
Phase II/III Clinical Trial of Sub-Tenon Injection of Triamcinolone Acetonide (WP-0508ST) for Diabetic Macular EdemaYuichiro Ogura, Masahiko Shimura, Tomohiro Iida, et al.
Antioxidants (Basel, Switzerland)|May 27, 2026
Involvement of Oxidative Stress-Related Inflammatory Mediators in the Pathogenesis and Treatment Response of Macular Edema Secondary to Branch Retinal Vein OcclusionTakuto Yamamoto, Hidetaka Noma, Tatsuya Mimura, et al.
Pageof 13